LZ1 peptide

LZ1 peptide is a antimicrobial peptides with antimalarial activity[1][2].

Product Specifications

CAS Number

[1423743-97-8]

UNSPSC

12352209

Target

Antibiotic; Bacterial

Type

Peptides

Related Pathways

Anti-infection

Applications

COVID-19-immunoregulation

Field of Research

Infection

Assay Protocol

https://www.medchemexpress.com/lz1-peptide.html

Solubility

10 mM in DMSO

Smiles

CC(C)[C@H](N)C(N[C@@H](CCCCN)C(N[C@@H](CCCNC(N)=N)C(N[C@@H](CC1=CNC2=CC=CC=C12)C(N[C@@H](CCCCN)C(N[C@@H](CCCCN)C(N[C@@H](CC3=CNC4=CC=CC=C34)C(N[C@H](C(N[C@@H](CCCNC(N)=N)C(N[C@@H](CCCCN)C(N[C@H](C(N[C@@H](CCCCN)C(N[C@@H](CCCCN)C(N[C@H](C(N[C@H](C(N)=O)C(C)C)=O)CC5=CNC6=CC=CC=C56)=O)=O)=O)CC7=CNC8=CC=CC=C78)=O)=O)=O)CC9=CNC%10=CC=CC=C9%10)=O)=O)=O)=O)=O)=O)=O

Molecular Formula

C113H167N33O15

Molecular Weight

2227.75

References & Citations

[1]Yaqun Fang, et al. In Vitro and In Vivo Antimalarial Activity of LZ1, a Peptide Derived from Snake Cathelicidin. Toxins (Basel) . 2019, 11, 7. |[2]Daniel J Cushing, et al. Reversal of heparin-induced increases in aPTT in the rat by PM102, a novel heparin antagonist. Eur J Pharmacol. 2010, 635, 1-3.